Lack of association between IL-1β/α gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis  by Ozkara, Cigdem et al.
Lack of association between IL-1b/a gene
polymorphisms and temporal lobe epilepsy with
hippocampal sclerosis
Cigdem Ozkara a,*, Mustafa Uzan b, Taner Tanriverdi b, Onur Baykara c,
Burcak Ekinci a, Naz Yeni a, Ali Kafadar b, Nur Buyru c
a Istanbul University, Cerrahpasa Medical Faculty, Department of Neurology, Istanbul, Turkey
b Istanbul University, Cerrahpasa Medical Faculty, Department of Neurosurgery, Istanbul, Turkey
c Istanbul University, Cerrahpasa Medical Faculty, Department of Medical Biology, Istanbul, Turkey
Received 27 June 2005; received in revised form 11 February 2006; accepted 17 February 2006
Seizure (2006) 15, 288—291
www.elsevier.com/locate/yseiz
KEYWORDS
Hippocampal sclerosis;
Interleukin;
Temporal lobe
epilepsy;
Genetics;
Cytokine,
Summary Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is
one of the most common medically intractable epilepsy syndromes and the pathogen-
esis of HS remains highly obscure. Recent studies demonstrated controversial results
about the relationship between interleukin (IL) gene polymorphism and epilepsy in
different ethnic groups. This correlation was investigated in Turkish patients with
MTLE-HS. The allele distribution of IL-1a and IL-1b in 47 patients of Turkish ancestry
was determined and compared with 99 ethnically matched control subjects. Analysis
of genotype frequencies between patients and controls showed no statistically
significant difference ( p > 0.05). Our data suggest that IL-1a and IL-1b gene poly-
morphisms do not act as a strong susceptibility factor for MTLE-HS in individuals of
Turkish ancestry.
# 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
At the present time, we do not know whether ‘‘the
truth is out there’’, but recent studies lead us to go
further to take ourselves closer to finding the exis-
tence of a genetic basis for epilepsy. Mesial tem-
poral lobe epilepsy with hippocampal sclerosis
(MTLE-HS) is the most common form of epilepsy* Corresponding author. Tel.: +90 212 6330176;
fax: +90 212 6330176.
E-mail address: cigdemoz@istanbul.edu.tr (C. Ozkara).
1059-1311/$ — see front matter # 2006 British Epilepsy Association
doi:10.1016/j.seizure.2006.02.016syndromes that often remains resistant to medical
therapy.1 Although several theories have been put
forth to describe the pathogenesis of HS, the main
mechanism(s) comprising the cascade of events that
may contribute to the etiology remain(s) obscure.
Genetic studies during the last 5 years have pre-
sented supportive2—5 as well as contradictory6—9
evidence related to the pathogenesis of MTLE-HS
and the discrepancy between data previously pub-
lished from different populations was mainly attrib-
uted to the ethnic differences.10 The immune
system is also another interesting field which may. Published by Elsevier Ltd. All rights reserved.
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proinflammatory cytokines, interleukin-1 beta (IL-
1b) and interleukin-1 alpha (IL-1a) are synthesized
during inflammation not only by macrophages but
also by glial and neuronal cells.11 Few studies have
examined the IL-1b gene as a genetic risk factor in
the development of HS but very little information
related to IL-1a has been presented.
Two biallelic base chance polymorphisms in IL-1b
and IL-1a genes have been reported in the long arm
of the chromosome 2. In the IL-1b, one is in the
promoter region at position 511 (IL-b 511) and
the other is in the exon 5 at position +3953 (IL-
1b + 3953).12 The IL-1a has a common polymorphism
in the 50 regulatory region (a C to T transition at
position 889 relative to the start site of transcrip-
tion), which gives rise to two alleles, allele 1 and
allele 2.13
In the present study, we have analyzed the
genetic polymorphism of IL-1b and -1a in patients
with MTLE-HS and ethnically matched healthy
blood donors. We wonder whether this cytokine
gene polymorphism is responsible in part for a
genetic susceptibility to MTLE-HS in the Turkish
population and we wanted to contribute to the
current literature with data about a different
ethnic group.Materials and methods
Patients and controls
Forty-seven patients with MTLE-HS were followed
at the Cerrahpasa Medical Faculty Epilepsy Center
and were included in the study. Diagnosis of MTLE-
HS was made based on clinical history, electroen-
cephalography, magnetic resonance imaging and
pathologic examination of resected tissue (43
patients). The control group (n = 99) comprised
unrelated, neurologically normal subjects. Both
patients and controls were of Turkish ancestry. All
patients or next of kin provided informed consent
for the study.Table 1 Clinical characteristics of patients and control gr
Parameters Patients (n = 47) Control
Sex (F/M) 28/19 43/56
Age (year) 20.0  9.2 25.8 
AEO (mo) 100.2  89.8
Simple FS
Prolonged FS
FHFS 18 (38.2%)
FHE 18 (38.2%)
AEO: Age at epilepsy onset; FS: Febrile seizure; FHE: Family historMolecular methods
All individuals provided a venous blood sample and
genomic DNA was prepared from blood leukocytes,
as described elsewhere.14 Each polymerase chain
reaction was carried out with 50 ng genomic DNA
and 1.0 U AmpliTaq Gold polymerase (Perkin-Elmer
Cetus, Branchburg, NJ). For optimal amplification,
the Mg+ concentration of the reaction buffer was
adjusted to 1.5 mM.
A single base pair polymorphism at position 511
in the promoter region and the polymorphic region
containing the TaqI (New England Biolabs, Inc, Bev-
erly, MA) restriction site at position +3953 within five
of the IL-1b gene were amplified according to Mans-
field and colleagues.15 A C-T transition polymorphism
at position 889 in the promoter region of the IL-1a
gene was analyzed according to McDowell et al.16
Data analysis
The chi-square (x2) or Fisher’s exact test analyzed
the allele frequencies between the patients and
matched healthy controls, using the standard SPSS
statistical program (SPSS, Chicago, Illinois, USA). A
‘‘p’’ value of less than 0.05 was considered statis-
tically significant.Results
The clinical characteristics of patients and controls
are summarized in Table 1. Although the age at
onset of epilepsy was earlier in patients with febrile
seizures (FS+) than without (FS), the difference did
not prove significant (90.9  89.4 months vs.
114.0  91.1 months, p = 0.37). No differences
were also noted between FS+ and FS patients with
regard to the family history of febrile seizure (FHFS)
and family history of epilepsy (FHE) ( p = 0.44).
The distribution of IL-1b and IL-1a genotypes in
patients with MTLE-HS and controls are demon-
strated in Table 2. The distribution of IL-1b
511 (p = 0.66) and IL-1b + 3953 ( p = 0.42) geno-oup
(n = 99) FS+ (n = 28) FS (n = 19)
17/11 11/8
11.5
90.9  89.4 114.0  91.1
24 (85.7%)
4 (14.2%)
12 (42.8%) 6 (31.5%)
11 (39.2%) 7 (36.8%)
y of epilepsy; FHFS: Family history of febrile seizure.
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Table 2 Association of MTLE-HS patients with IL-1b and IL-1a genotypes
Genotypes MTLE-HS (%) Control (%) FS+ (%) FS (%) ‘‘p’’
MTLE-HS vs. control FS+ vs. FS
Total 47 99 28 (59.5) 19 (40.4)
IL-1b 511
1/1 16 (34.0) 41 (41.4) 9 (32.1) 5 (26.3) 0.66 0.66
1/2 21 (44.6) 41 (41.4) 13 (46.4) 9 (47.3)
2/2 10 (21.2) 17 (17.1) 6 (21.4) 5 (26.3)
IL-b +3953
1/1 28 (59.5) 63 (63.6) 19 (67.8) 12 (63.1) 0.42 0.47
1/2 18 (38.2) 30 (30.3) 9 (32.1) 7 (36.8)
2/2 1 (2.1) 17 (17.1) 0 (0) 0 (0)
IL-1a 889
1/1 23 (48.9) 37 (37.3) 16 (57.1) 9 (47.3) 0.14 0.67
1/2 23 (48.9) 52 (52.5) 12 (42.8) 10 (52.6)
2/2 1 (2.1) 10 (10.1) 0 (0) 0 (0)
MTLE-HS: Mesial temporal lobe epilepsy with hippocampal sclerosis; FS+: Febrile seizure positive; FS: Febrile seizure negative.types was not significantly different between MTLE-
HS patients and controls. When compared to the
MTLE-HS patients with controls with respect to IL-1a
889, the chi-square test also showed no significant
result (p = 0.14). Concerning the difference
between FS+ and FS patients with respect to allele
distribution, no statistically significant difference
was found regarding IL-1b 511, IL-1b +3953, and
IL-1a 889 (p values 0.66, 0.47, and 0.67, respec-
tively). One-tailed Fisher’s exact test performed on
the allele distribution also showed no significant
difference among the groups.
In patients and controls, the homozygous
(511*1/1, +3953*1/1, and 889*1/1) and hetero-
zygous types (511*1/2, +3953*1/2, and 889*1/2)
are commonly seen genotypes in this Turkish sample.
The level of significance was found to be 46%
(delta: 0.18, alpha: 0.05 and power: 0.46) due
mainly to the small number of both the patient
and control groups. However, the power was taken
into consideration during the statistical analysis.Discussion
Although there are clinical and experimental studies
on cytokines, antibodies and HLA system,17,18 immu-
nological parameters seemed to be underestimated
in the pathogenesis of HS comparing with the other
etiological factors.
Following the first study by Kanemoto et al.2 who
showed the associations between polymorphism in
the IL-1b gene and MTLE-HS, supportive as well as
apparently contradictive studies have begun to
appear in the literature. They reported an overre-
presentation of thehypothesized susceptibility allele(511T) in Japanese TLE + HS patients with a fre-
quency of 0.63 compared with 0.46 in controls,
whereas in the present study, no significant differ-
ences were observed. In a Finnish sample, Peltola
et al.3 investigated cytokine gene polymorphism in
patients with drug-resistant partial epilepsy and
showed that patients who carry promoter 511T
allele and noncarriers of IL-IRA allele 2 are more
prone to have inflammatory responses which may
increase susceptibility to develop intractable epi-
lepsy. In another study, Virta et al.4 supported the
genetic basis demonstrating an increased frequency
of IL-1b511T in children with FS and proposed that
this allele may give rise to in vitro IL-1 production
which may exaggerate the proinflammatory reac-
tions during fever. Furthermore, Kanemoto et al.5
extended their previous study by increasing the num-
ber of subjects and they examined the impact of
prolonged FS on IL-1b genotype distribution. They
reproduced their previous results showing that the
distributionof the IL-1b511genotypewasmarkedly
different in patientswithMTLE-HS than controls. The
frequency of 511T allele was highest in patients
with prolonged FS, intermediate with simple FS, and
lowest without either simple or prolonged FS.
In contrast to the studies mentioned above, Heils
et al.6 in a German sample, Buono et al.7 in an
American sample, and Jin et al.19 in Chinese samples,
and the present data in a Turkish sample failed to
demonstrate any significant difference in genotype
and allele frequencies between MTLE-HS patients
andcontrols.On theotherhand, other studies carried
out on patients with FS could not also demonstrate
any association between IL-1 b and a tendency for FS
(Tilgen et al.8 in a German sample, Tsai et al.9 in a
Taiwanese sample, Kira et al.20 in a Japanese sam-
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results as they found no statistically significant dif-
ference between 73 children with FS and 152 healthy
controls regarding IL-1b 511 and IL-1a 889 geno-
types.21 Our comparison of patients with FS- and FS+
within the MTLE group was also concordant with
these results showing no difference.
Furthermore, other promoter regions: exon 5 at
position +3953 (IL-1b +3953) and IL-a 889 that
were investigated in this study again failed to show
any significant difference in the frequency distribu-
tion of alleles among controls and patients. Both
genotype or allele frequencies determined here are
consistent with the bulk of the studies reported in
the literature that showed no association between
the IL-1b nor IL-1a gene polymorphisms and tem-
poral lobe epilepsy and FS.4,7—9,19—21 However,
almost all of the studies including ours, used small
numbers of patients, limiting the statistical power
to detect susceptibility factors of minor or moder-
ate influence. Neverthless, this does not mean to
negate or disprove the existence of a susceptibility
gene which has been supported by other investiga-
tors. The differences in ethnic background may play
a major role in the discrepancies obtained from the
studies as well. Therefore, we need further studies
with larger patient populations to discuss and con-
sider a significant association.Conclusion
In conclusion, no correlation was found between IL-
1 a/b gene polymorphisms and MTLE-HS in Turkish
patients. Apparently, this field is waiting for more
research to establish a meaningful link between the
immune system and epilepsy.Acknowledgement
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